BioSpace News Archive

Be Biopharma, Inc. (“Be Bio”) announced that it will present new data from preclinical research and collaboration programs at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting taking place May 16-20, 2023, in Los Angeles, Calif.

Quanterix Corporation, a company fueling scientific discovery through ultrasensitive biomarker detection, announced it will host a conference call on Tuesday, May 9, 2023, to discuss its first quarter 2023 financial results.

Metagenomi, a genetic medicines company with a versatile portfolio of wholly owned, next-generation gene editing systems, announced it will present new data during the 26th American Society of Gene + Cell Therapy (ASGCT) Annual Meeting in Los Angeles (May 16-20).

Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”) today announced two oral presentations and two poster presentations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, being held May 16-20, 2023, in Los Angeles, CA.

uniQure N.V. (NASDAQ: QURE) today announced that 12 data presentations, including two oral presentations, will be delivered at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting being held May 16-20 in Los Angeles, California.

Dyne Therapeutics, Inc. (Nasdaq: DYN) today announced that new preclinical data demonstrating the FORCE™ platform achieved delivery to the central nervous system (CNS) and robust pharmacological effects in the brain will be featured in an oral presentation at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting.

Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, announced today that it will share initial preclinical data on its in vivo Gene Placement System (iGPS™) technology during an oral presentation at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting.

2seventy bio, Inc. (Nasdaq: TSVT) today announced the presentation of five abstracts, including one late-breaking oral presentation, at this year’s American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, taking place in Los Angeles, California from May 16-20, 2023.

MannKind Corporation will release its 2023 first quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM on Tuesday, May 9, 2023.

REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting, taking place in Los Angeles, California from May 16 through 20, 2023.